课题基金 / 基金详情

Pathological Significance of Gene Polymorphisms of the Renin-Angiotensin System in Hypertension.

Pathological Significance of Gene Polymorphisms of the Renin-Angiotensin System in Hypertension.
肾素-血管紧张素系统基因多态性在高血压中的病理意义。
批准号:
09672347
负责人:
YASUJIMA Minoru
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

YASUJIMA Minoru的其他基金

相似基金

相关文献

中文摘要
翻译
肾素-血管紧张素系统(RAS)在血压和局部血流的调节中起着重要作用。RAS的3个主要成分血管紧张素原、血管紧张素转换酶(ACE)和血管紧张素II 1型受体(AT 1 R)的基因多态性已被认为是高血压及其并发症的可能遗传标记。高血压和高血压心血管疾病的死亡率和发病率在青森人口中很高。因此,我们试图确定在高血压和正常血压的受试者生活在青森县的这些组件的显着的3个基因变异的患病率。终末期肾病(ESRD)患者和脑血管疾病患者也入组本研究。血管紧张素原M235 T和ACE I/D基因多态性与高血压呈正相关。而AT 1 R A1166 C多态性在高血压组和正常血压组之间不存在不平衡。ACE I/D也与脑血管疾病相关,但与ESRD无关。这些结果表明,血管紧张素原M235 T和ACE I/D变异体可能是高血压的遗传易感因素,ACE I/D可能进一步促进脑血管疾病作为青森人群的遗传标记。
英文摘要
The renin-angiotensin system (RAS) plays an important role in the regulation of blood pressure and regional blood flow. Gene polymorphisms of 3 major components of the RAS, angiotensinogen, angiotensin converting enzyme (ACE) , and angiotensin II type 1 receptor (AT1R) have been raised as possible genetic markers for hypertension and its complications. The mortality and morbidity of hypertension and hypertensive cardiovascular diseases are high in the Aomori population. Therefore, we tried to identify the prevalence of significant 3 gene variants of those components in hypertensive and normotensive subjects living in Aomori prefecture. Patients with end-stage renal disease (ESRD) and patients with cerebrovascular diseases were also enrolled in this study. Positive linkages were identlfied between hypertension and 2 gene polymorphisms including angiotensinogen M235T and ACE I/D. However, disequilibriums in AT1R A1166C polyrrmorphism was absent between hypertensive and normotensive groups. ACE I/D was also associated with cerebrovascular diseases, but not with ESRD.These results suggest that the angiotensinogen M235T and ACE I/D variants may be genetic-susceptibility factors for hypertension and that ACE I/D may further contribute to cerebrovascular diseases as a genetic marker in the Aomori population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kohzuki M, Wu XM, Kamimoto M, Yoshida K, Nagasaka M, Kanazawa M, Yasujima M, Saito T, Sato T: "Renal-protective effect of non-depressor dose of cicletanine in diabetic rats with hypertension."Am J Hypertension. (in press).
Kohzuki M、Wu XM、Kamimoto M、Yoshida K、Nagasaka M、Kanazawa M、Yasujima M、Saito T、Sato T:“非抑制剂剂量的西克莱他宁对高血压糖尿病大鼠的肾脏保护作用。”Am J 高血压。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Murakami H, Tamasawa N, Matsui J, Yasujima M, Suda T: "High levels of plasma oxysterols and augmented cholesterol oxidizability in patients with diabetes mellitus"Lipids. (in press).
Murakami H、Tamasawa N、Matsui J、Yasujima M、Suda T:“糖尿病患者血浆氧甾醇水平高,胆固醇氧化能力增强”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Murakami H., Yasujima M. et al.: "High levels of plasma oxysterols and augmented cholesterol oxidizability in patients with diabetes mellitus"Lipids. (in press).
Murakami H.、Yasujima M. 等人:“糖尿病患者血浆氧甾醇水平高,胆固醇氧化能力增强”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 13 条
    Clinical significance of SLC12A3 gene polymorphisms in diabetic nephropathy
    • 批准号:
      19590546
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2007
    • 负责人:
      YASUJIMA Minoru
    • 依托单位:
    Clinical Significance of Sodium Metabolism-related Gene Polymorphisms in Salt-Sensitive Hypertension
    • 批准号:
      15590477
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2003
    • 负责人:
      YASUJIMA Minoru
    • 依托单位:
    The significance of endothelial nitric oxide synthase gene polymorphisms as genetic markers of hypertensive disorders
    • 批准号:
      12672236
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      YASUJIMA Minoru
    • 依托单位:
    Characterization, localization and quantification of neutral metalloendopeptidase, the degradative enzyme for atrial natriuretic peptide
    • 批准号:
      04670511
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1992
    • 负责人:
      YASUJIMA Minoru
    • 依托单位:
    国内基金
    海外基金
    HIF-2α-Snail调节环路在肺血管内皮转化过程中的作用机制研究
    • 批准号:
      81870046
    • 项目类别:
      面上项目
    • 资助金额:
      54.0万元
    • 批准年份:
      2018
    • 负责人:
      赖宁
    • 依托单位:
    硫化氢通过核转录因子-kB信号途径调节高血压大鼠血管平滑肌细胞增殖的研究
    • 批准号:
      81070212
    • 项目类别:
      面上项目
    • 资助金额:
      33.0万元
    • 批准年份:
      2010
    • 负责人:
      金红芳
    • 依托单位:
    内源性硫化氢调控高血压血管基质重塑的研究
    • 批准号:
      30801251
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2008
    • 负责人:
      金红芳
    • 依托单位: